People: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

9.34USD
19 Jun 2013
Price Change (% chg)

$-0.26 (-2.71%)
Prev Close
$9.60
Open
$9.65
Day's High
$9.68
Day's Low
$9.22
Volume
299,252
Avg. Vol
436,912
52-wk High
$10.59
52-wk Low
$2.27

Search Stocks

Welch, James 

Brief Biography

Mr. James H. Welch is Chief Financial Officer of AcelRx Pharmaceuticals Inc. From June 2006 until September 2010, Mr. Welch served as Chief Financial Officer and Corporate Secretary for Cerimon Pharmaceuticals, a biopharmaceutical company. Mr. Welch served as Vice President, Chief Financial Officer and Corporate Secretary for Rigel Pharmaceuticals, Inc., a drug development company from October 2000 until May 2006, and as Vice President, Finance and Administration for Rigel Pharmaceuticals, Inc. from May 1999 until October 2000. From June 1998 until May 1999, Mr. Welch served as an independent consultant at various companies. Mr. Welch served as Chief Financial Officer of Biocircuits Corporation, a company focused on developing immunodiagnostic testing systems from February 1997 until June 1998, and from June 1992 until February 1997, he served as Corporate Controller of Biocircuits Corporation. Mr. Welch holds a B.A. in Business Administration from Whitworth College and an M.B.A. from Washington State University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
564,793 -- -- 564,793

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Adrian Adams

--

Richard King

1,212,610

James Welch

564,793

Pamela Palmer

1,075,580

Badri Dasu

492,564

Lawrence Hamel

508,560
As Of 30 Dec 2012
Search Stocks